Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Poor economy hits AMO's 2008 outlook

This article was originally published in Clinica

Executive Summary

The weakening economy has dealt a bigger-than-expected blow to Advanced Medical Optics' US and European laser vision correction businesses, resulting in the company having to slash its revenue and profit outlook for 2008. The Santa Ana, California firm is now expecting revenue for the year to be between $1.7-1.2bn, down from the previous forecast of $1.22-1.24bn. Earnings-per-share is anticipated to sink below the $1-mark to reach between $0.70-0.80, compared with $1-1.15 as previously expected. The news sent AMO's shares plunging to an all-time low, closing at $6.83 per share on Friday (October 10).One silver lining in the cloud was the company's performance in the Japanese and Asia-Pacific markets, which the firm said was growing at double digit rates.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040859

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel